BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
92.80
-0.87 (-0.93%)
At close: Aug 10, 2026, 4:00 PM EDT
93.40
+0.60 (0.65%)
Pre-market: Aug 11, 2026, 8:21 AM EDT
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of $23.31 billion as of August 11, 2026. Its market cap has decreased by -13.15% in one year.
Market Cap
23.31B
Enterprise Value
8.29B
1-Year Change
-13.15%
Ranking
Category
Stock Price
$92.80
ChartMarket Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from $2.99B to $23.31B, an increase of 678.36%. That is a compound annual growth rate of 35.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 23.31B | 1.84% |
| Dec 31, 2025 | 22.89B | -16.21% |
| Dec 31, 2024 | 27.32B | 8.89% |
| Dec 29, 2023 | 25.09B | -31.28% |
| Dec 30, 2022 | 36.51B | -41.37% |
| Dec 31, 2021 | 62.26B | 217.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 39.60B |
| Royalty Pharma | 32.64B |
| Alnylam Pharmaceuticals | 29.33B |
| Insmed | 28.63B |
| Roivant Sciences | 26.25B |
| Incyte | 24.44B |
| Moderna | 23.62B |
| Genmab | 18.45B |